We're excited to introduce GeoDirDock (GDD), our new diffusion model for directed docking.
This work has been accepted at the Generative and Experimental Perspectives for Biomolecular Design Workshop at ICLR. You can check out the paper here: https://t.co/T84g26ysVA .
The future of XNA research starts in @HelloNostrum, led by the Nucleic Acids Director @_VitoGenna_ , in collaboration with @IRBBarcelona, Instituto de Química Avanzada de Cataluña (IQAC-CSIC), and @iqf_csic, @CSIC.
The first-ever database and molecular modeling XNA research tool
2024: XNA-hub, a first-worldwide platform designed to streamline XNA research
XNA-hub is more than a resource; it's a meticulously curated powerhouse designed for flexibility and scalability, contributing to the advancement of research in this dynamic field.
Stay tuned
#rna
2/2. Time to present our second work accepted to the AccMLBio Workshop at @icmlconf on Machine Learning'24 where we posed the following question: Are protein language models (pLMs) compute optimal?
You can check the paper out here: https://t.co/p6D2xHsRNy
1/2. We are pleased to share that we just have had two papers accepted to @icmlconf Workshops. Today, we will delve into one of them: ScoreFormer.
ScoreFormer is an integral part of our ALScreen platform. Take a look at the paper here: https://t.co/Qk3kJoihLF
🎙Episodio [23]
DESCUBRIENDO FÁRMACOS CON INTELIGENCIA ARTIFICIAL
👩🔬Con #LucíaDíazBueno de @HelloNostrum@PCB_UB
Hablamos de 💊💻🛫🤾♀️🇸🇪🐖🍷
https://t.co/bR31ejaPPb
@HelloNostrum will travel to the land of the rising sun ☀️🇯🇵
We are one of the biotech companies sharing its experiences in the Spanish Pavilion hand by hand with @ICEX_ at @BioJapanExpo ,from October 11 to October 13.
Find us at Booth C-13 https://t.co/zM0cvFVhNJ
On October 5 and 6, we'll be in Amsterdam for the 13th Drug Discovery Strategic Summit.
Our director of artificial intelligence @alexismolinamr will present the session, titled "Informed lead generation from the screening of ultra-large databases," during the conference.
#SpinOffUB | 🚀 Èxit de les ‘spin-offs’ de la Universitat de Barcelona: cinc empreses superen el milió d’euros de facturació el 2022.
📈 En total, les empreses derivades de la UB van facturar 11,4 milions d’euros, un increment del 22%.
👉 https://t.co/8SXke9CyLa
Sign in for a more detailed view on AI driven HTVS and on how we leverage generative models to surpass IP crowded spaces in relevant targets.
Thanks @ccpbiosim for having me!
An Intense and exciting first day at the Drug Discovery Innovation Program https://t.co/AVNrOA5dI6
After an inspiring talk about "The #AI Revolution in Virtual Screening" performed by our #CSO, Victor Guallar.
Waiting for you at the SB GLOW Barcelona
🎙️ No te pierdas este entrevista de @COPE Catalunya a la Dra. @DirenaAC, del equipo de investigadores #IRBBarcelona-@MSKCancerCenter que descubrió un mapa epigenético en alta resolución que revela las conversaciones celulares que inician el #CáncerdePáncreas.
📻Escúchala aquí👇
🧬L'estructura d'una proteïna unida a l'ADN revela com s'activa la toxicitat del bacteri del #còlera.
🔬Científics d'#IRBBarcelona, @IBMB_CSIC i @detmercy descobreixen l'estructura atòmica de la proteïna #ToxR unida a l'ADN.
📰@PNASNews
➡️https://t.co/nHBu46YC3H
#IRBScience